- Credit Amounts:
- CME: 2.00
- BOC: 1.75
- Cost: $25.00
- Release: Nov 1, 2015
- Expires: Dec 31, 2017
- Estimated Time to Complete:
- System Requirements:
Average User Rating:
Director of Musculoskeletal Laboratory
Professor, Athletic Training
College of Health Sciences
University of Kentucky
Needs StatementSurgical management of Superior Labral Anterior-Posterior (SLAP) Tears has been on an unprecedented upswing in surgical case reported at the board examination for orthopedic surgeons. The surgical cases presented are three times greater the likely incidence of SLAP Tears. Unfortunately, the return to play following surgery in overhead athlete is only averaging 63% return rate. At the same time there is only 3 published articles in the English literature that have investigated the benefit on non-operative management of SLAP lesion. There is a relative dearth of information on what is the best way to manage these patients from both non-operatively and post-operatively perspective. This very common diagnose requires further investigation so that athletic trainers understand what challenge their athletes are faced with when diagnosed with a SLAP lesion. This presentation will help educate clinicians about their patients’ prognosis of both non-operative and operative outcomes for SLAP lesions and describe key elements in designing an effective rehabilitation intervention.
Target AudienceThis activity is designed for athletic trainers, physical therapists, sports medicine physicians, physical medicine and rehabilitation physicians, and physician assistants.
ObjectivesAt the conclusion of the session, attendees will be able to:
1. Describe how to integrate a non-operative rehabilitation program into their clinical management of SLAP lesions.
2. Educate their patients on the prognosis of both non-operative and operative outcomes for SLAP lesions.
3. Recall a post-operative rehabilitation program for type 2 SLAP tears
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Kentucky College of Medicine, and UK College of Health Science. The University of Kentucky College of Medicine is accredited by the ACCME to provide continuing medical education for physicians. The University of Kentucky College of Medicine designates this enduring material for a maximum of 2.00 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity. The University of Kentucky College of Medicine presents this activity for educational purposes only. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentations is provided solely by presenters who have been selected for presentations because of recognized expertise in their field.
- Patient care
- Medical knowledge
- Practice-based learning and improvement
The University of Kentucky is recognized by the Board of Certification, Inc. to offer continuing education for Certified Athletic Trainers. This program has been approved for a maximum of 1.75 hours of EBP Category continuing education. Certified Athletic Trainers are responsible for claiming only those hours actually spent participating in the continuing education activity.
BOC Approved EBP Provider Number: P2382-5
Faculty DisclosureTimothy L. Uhl, PhD, PT, ATC (Speaker) has relevant financial relationships with commercial interests as follows:
New Option Sports, Inc - Inventor - Royalties
Patterson Medical Supply, Inc - Independent Contractor - Research Grant
No (other) speakers or planners have any relevant financial relationships to disclose.
The material presented in this course represents information obtained from the scientific literature as well as the clinical experiences of the speakers. In some cases, the presentations might include discussion of investigational agents and/or off-label indications for various agents used in clinical practice. Speakers will inform the audience when they are discussing investigational and/or off-label uses.
Content review confirmed that the content was developed in a fair, balanced manner free from commercial bias. Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.